1673-6583
2008 Issue 5
zi fa xing shi guan zuo shi po lie shi guan xiong mo zuo wu zhen 1 li
wei fu qi ; wang da gang
wei fu qi ; wang da gang
..............page:333
zuo xin shi xue shuan you zuo you guan zhuang dong mai tong shi gong xue 1 li
gu guo qiang ; cui zuo ; yang xiao hong ; liu su ; liu lin li ; chen li hua ; li bao hua ; wu jin feng ; yang xiu shang
gu guo qiang ; cui zuo ; yang xiao hong ; liu su ; liu lin li ; chen li hua ; li bao hua ; wu jin feng ; yang xiu shang
..............page:322
e bei sha tan de jiang ya zhi liao he ba qi guan bao hu
zhou jing min
zhou jing min
..............page:334-336
..............page:329-333
guan zhu fei xin zang shou shu wei shou shu qi xin xue guan wen ti de ping gu he chu li
luo xin ping ; fan wei zuo
luo xin ping ; fan wei zuo
..............page:325-328
Safety and efficacy of rapamycin-eluting stent coated with biodegradable polymer made in China
HU Hao;CHANG Peng;BAI Feng;GUO Xueya;LIN Xin
HU Hao;CHANG Peng;BAI Feng;GUO Xueya;LIN Xin
..............page:323-324
Histology and pgp9.5 protein distribution in the pulmonary vein tissues of patients with atrial fibrillation and rheumatic heart valve disease
ZHOU Yong;LI Li;XU Zhiyun;ZOU Liangjian;HAN lin;XU Jibin;LU fanglin
ZHOU Yong;LI Li;XU Zhiyun;ZOU Liangjian;HAN lin;XU Jibin;LU fanglin
..............page:320-322,图版一
Effects and mechanism of magnesium gluconate on myocardial cell apoptosis in rats with ischemia reperfusion injury in vitro
TAO Guizhou;HE Xin
TAO Guizhou;HE Xin
..............page:316-319
Association between PAI-2 gene polymorphism and coronary heart disease
ZHAO Nan;ZHANG Jin;ZHANG Zheng
ZHAO Nan;ZHANG Jin;ZHANG Zheng
..............page:312-315
Complications and their prevention of radiofequency ablation for atrial fibrillation
YIN Zhiqiang;XU Geng
YIN Zhiqiang;XU Geng
..............page:309-311
Interventional therapy for mitral regurgitation
DU Xiangfeng;YE Honghua;CHU Huimin
DU Xiangfeng;YE Honghua;CHU Huimin
..............page:305-308
Clinical application of percutaneous aortic valve replacement
HUA Sha;ZHANG Guobing
HUA Sha;ZHANG Guobing
..............page:301-304
Advances in molecular biological mechanism of thoracic anenrysm
WANG Wei;CHEN Yin;SHEN Weifeng
WANG Wei;CHEN Yin;SHEN Weifeng
..............page:297-300
Paraoxonase genes and atherosclerotic oxidative stress
GAO Lin;WU Zonggui
GAO Lin;WU Zonggui
..............page:294-296,311
Studies on matrix mettalproteinase and related inhibitors
YAO Yiqin;XIE Meilin
YAO Yiqin;XIE Meilin
..............page:290-293
Relationship between matrix mettalproteinase and arterial stiffness
YAN Zijun;ZHANG Ruiyan
YAN Zijun;ZHANG Ruiyan
..............page:287-289,304
..............page:284-286,304
PAPP-A and cardiovascular disease
LI Xiaolan;WANG Xiang
LI Xiaolan;WANG Xiang
..............page:279-283
Cardiac actions of β3 adrenoceptors
YE Xuying;LU Chengzhi
YE Xuying;LU Chengzhi
..............page:276-278,283
Homeostatic effects of vasoslatin-1 in cardiovnscular system
WANG Zheng;XIAO Mingdi
WANG Zheng;XIAO Mingdi
..............page:272-275
Experimental studies of mechanisms of myocardial stunning
ZHANG Yan;LI Xiaoying;YING Mingzhong
ZHANG Yan;LI Xiaoying;YING Mingzhong
..............page:269-271
Signal transduction of myocardial hypertrophy
YANG Xiaohui;LU Xinzheng
YANG Xiaohui;LU Xinzheng
..............page:265-268